Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7573971

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
80,707,000,000 JPY
105,534,000,000 JPY
77,717,000,000 JPY
Ordinary profit (loss)
5,336,000,000 JPY
5,569,000,000 JPY
3,515,000,000 JPY
Net assets
126,788,000,000 JPY
124,507,000,000 JPY
122,853,000,000 JPY
Total assets
174,562,000,000 JPY
171,924,000,000 JPY
169,106,000,000 JPY
Basic earnings (loss) per share
76.40
54.71
68.62
43.34
41.21
Diluted earnings per share
Equity-to-asset ratio
0.726 xbrli:pure
0.724 xbrli:pure
0.726 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.